Abi enhances Abl-mediated Cdc2 phosphorylation and inactivation

Journal of Biomedical Science

Volumn 11, Issue 6, 2004, Pages 902-910

  Lin, Tzu Yang ^a,b   Huang, Chiu Hui ^a,b   Chou, Wen Gang ^b   Juang, Jyh Lyh ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Abelson interacting protein; Abelson tyrosine kinase; Adaptor protein; Cdc2 protein; Tyrosine phosphorylation

Indexed keywords

ABELSON KINASE; ADAPTOR PROTEIN; CELL CYCLE PROTEIN; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DROSOPHILA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TWO HYBRID SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CDC2 PROTEIN KINASE; CELL PROLIFERATION; COS CELLS; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; EVOLUTION, MOLECULAR; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MODELS, GENETIC; PHOSPHORYLATION; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-ABL; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 10844271184     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000081837     Document Type: Article

References (32)

1. 2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents. Blood 86:1148-1158;1995.
2. Biesova Z, Piccoli C, Wong WT. Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene 14:233-241;1997.
3. Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ, Lydon NB. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 56:100-104;1996.
4. Dai Z, Pendergast A. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev 9:2569-2582;1995.
5. Fan PD, Goff SP. Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases. Mol Cell Biol 20:7591-7601;2000.
6. Ferris DK, White GA, Kelvin DJ, Copeland TD, Li CC, Longo DL. p34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinase. Cell Growth Differ 2:343-349;1991.
7. Flynn DC. Adaptor proteins. Oncogene 20:6270-6272;2001.
8. Gotoh A, Broxmeyer HE. The function of BCR/ABL and related proto-oncogenes. Curr Opin Hematol 4:3-11;1997.
9. Ichigotani Y, Yokozaki S, Fukuda Y, Hamaguchi M, Matsuda S. Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. Cancer Res 62:2215-2219;2002.
10. Ikeguchi A, Yang HY, Gao G, Goff SP. Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1. Oncogene 20:4926-4934;2001.
11. Juang J-L, Hoffmann FM. Drosophila Abelson interacting protein (dAbi) is a positive regulator of Abelson tyrosine kinase activity. Oncogene 18:5138-5147;1999.
12. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR, Kufe DW. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376:785-788;1995.
13. Kipreos ET, Wang JY. Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science 248:217-220;1990.
14. Lee DF, Chen CC, Hsu TA, Juang JL. A baculovirus superinfection system: Efficient vehicle for gene transfer into Drosophila S2 cells. J Virol 74:11873-11880;2000.
15. Miyazaki K, Matsuda S, Ichigotani Y, Takenouchi Y, Hayashi K, Fukuda Y, Nimura Y, Hamaguchi M. Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochim Biophys Acta 1493:237-241;2000.
16. Morgan DO. Principles of CDK regulation. Nature 374:131-134;1995.
17. Nebreda AR, Gannon JV, Hunt T. Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes. Embo J 14:5597-5607;1995.
18. Nishii K, Kabarowski JH, Gibbons DL, Griffiths SD, Titley I, Wiedemann LM, Greaves MF. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block. Oncogene 13:2225-2234;1996.
19. Nurse P. Checkpoint pathways come of age. Cell 91:865-867;1997.
20. Ramet M, Pearson A, Manfruelli P, Li X, Koziel H, Gobel V, Chung E, Krieger M, Ezekowitz RA. Drosophila scavenger receptor CI is a pattern recognition receptor for bacteria. Immunity 15:1027-1038;2001.
21. Rogers SL, Wiedemann U, Stuurman N, Vale RD. Molecular requirements for actin-based lamella formation in Drosophila S2 cells. J Cell Biol 162:1079-1088;2003.
22. Schneider I. Cell lines derived from late embryonic stages of Drosophila melanogaster. J Embryol Exp Morphol 27:353-365;1972.
23. Scita G, Nordstrom J, Carbone R, Tenca P, Giardina G, Gutkind S, Bjarnegard M, Betsholtz C, Di Fiore PP. EPS8 and E3B1 transduce signals from Ras to Rac. Nature 401:290-293;1999.
24. Shi Y, Alin K, Goff S. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev 9:2583-2597;1995.
25. 2/M phase, and protection from apoptosis. Mol Cell Biol 22:4189-4201;2002.
26. Stiewe T, Parssanedjad K, Esche H, Opalka B, Putzer BM. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Cancer Res 60:3957-3964;2000.
27. Stradal T, Courtney KD, Rottner K, Hahne P, Small JV, Pendergast AM. The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Curr Biol 11:891-895;2001.
28. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H, Shishido T. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 278:21685-21692;2003.
29. Van Etten RA. Cycling, stressed-out and nervous: Cellular functions of c-Abl. Trends Cell Biol 9:179-86;1999.
30. Wang B, Mysliwiec T, Krainc D, Jensen RA, Sonoda G, Testa JR, Golemis EA, Kruh GD. Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. Oncogene 12:1921-1929;1996.
31. Zou X, Calame K. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J Biol Chem 274:18141-18144;1999.
32. Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, Gertler FB, Vidal M, Van Etten RA, Tsai LH. Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron 26:633-646;2000.